UBS Group’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.95K Sell
793
-527
-40% -$1.33K ﹤0.01% 9171
2025
Q4
$3.17K Buy
1,320
+281
+27% +$1.24K ﹤0.01% 9087
2025
Q3
$5.92K Sell
1,039
-8,110
-89% -$62.5K ﹤0.01% 8817
2025
Q2
$39K Buy
+9,149
New +$105K ﹤0.01% 7977
2025
Q1
Sell
-15
Closed -$281 10453
2024
Q4
$281 Buy
+15
New +$428 ﹤0.01% 9536
2024
Q3
Sell
-2,906
Closed -$221K 9756
2024
Q2
$221K Buy
+2,906
New +$312K ﹤0.01% 5593
2023
Q3
Sell
-7
Closed -$955 9683
2023
Q2
$955 Sell
7
-8
-53% -$2.39K ﹤0.01% 8057
2023
Q1
$6.9K Sell
15
-3
-17% -$2.55K ﹤0.01% 7868
2022
Q4
$18K Buy
18
+10
+125% +$16.2K ﹤0.01% 7774
2022
Q3
$21K Buy
8
+4
+100% +$10.2K ﹤0.01% 7325
2022
Q2
$10K Buy
4
+3
+300% +$7.61K ﹤0.01% 7965
2022
Q1
$2K Sell
1
-4
-80% -$10.1K ﹤0.01% 9638
2021
Q4
$13K Buy
5
+1
+25% +$2.5K ﹤0.01% 8453
2021
Q3
$11K Sell
4
-8
-67% -$19.8K ﹤0.01% 7882
2021
Q2
$31K Buy
12
+11
+1,100% +$27.2K ﹤0.01% 6883
2021
Q1
$3K Buy
+1
New +$2.45K ﹤0.01% 8514

Other funds holding ICU

UBS Group's ICU Position: Q1 2026 in Review

UBS Group reduced its SeaStar Medical (ICU) stake by 40% in Q1 2026, selling an estimated $1.33K and leaving 793 shares worth $2.95K. The position accounts for ﹤0.01% of the portfolio, ranked #9171.

UBS Group first reported a position in ICU in Q1 2021 and has held it in 16 quarters since. The position peaked at $221K in Q2 2024. 17 funds tracked by Wall St. Rank hold ICU as of Q1 2026.

  • UBS Group held 793 shares of SeaStar Medical worth $2.95K as of Q1 2026.
  • UBS Group sold 527 SeaStar Medical shares in Q1 2026, an estimated $1.33K.
  • SeaStar Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9171 holding.
  • UBS Group first reported a position in SeaStar Medical in Q1 2021 and has held it in 16 quarters since.
  • UBS Group's SeaStar Medical position peaked at $221K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held SeaStar Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.